- Email: [email protected]
Effects of Potassium Citrate on Irritative Voiding Symptoms of Bladder
SUNDAY, OCTOBER 18
POSTER SESSION: PROFESSIONAL SKILLS; NUTRITION ASSESSMENT; MEDICAL NUTRITION THERAPY Effects of Potassium Citrate on Irritative Voiding Symptoms of Bladder Author(s): J. Beary; Nutrition and Exercise Physiology, Washington State University Spokane Riverpoint Campus, Spokane, WA Learning Outcome: Participants will learn that potassium citrate may be a contributor to irritative voiding symptoms. A causative relation between diet and disease is recognized for a number of food substances and body organs. Participants completed a Block’s FFQ, the American Urological Association (AUA) Symptoms score sheet, 3-day voiding diary and 3-day food record. Eleven participants completed the 12-day diet study. Study utilized randomized crossover and participants were divided into two groups. For the first 6 days one group was given a placebo and the other potassium citrate, then for the final 6 days the administering was switched. Potassium citrate and placebo were taken during morning and evening meals. A total of 40 mEq of potassium was consumed per day for six days. On days 1, 3, 6, 9, and 12 participants completed AUA Symptoms score sheet, voiding diary and 24 hour urine samples. Comparisons between and within groups were made by repeated-measures analysis of variance. Change regarding urgency between groups from baseline to Day 12 was significant (P ⬍ .05). Two-way repeated measures suggest that urgency symptom changed over time during the six days when 40 mEq potassium citrate was consumed. The AUA Symptoms score sheet was used to report participants irritative voiding symptoms every three days of the 12-day study. Statistical significance was noted in quality of life scores between baseline and Day 6 and between baseline and Day 12 (P ⬍ .05). Results suggest that quality of life scores for both groups were the same at baseline but changed over time. Results suggest that potassium citrate (40 mEq) contributed to reported symptom variations. Funding Disclosure: WSU Seed Grant
Journal of the AMERICAN DIETETIC ASSOCIATION / A-41
POSTER SESSION: PROFESSIONAL SKILLS; NUTRITION ASSESSMENT; MEDICAL NUTRITION THERAPY Effects of Potassium Citrate on Irritative Voiding Symptoms of Bladder Author(s): J. Beary; Nutrition and Exercise Physiology, Washington State University Spokane Riverpoint Campus, Spokane, WA Learning Outcome: Participants will learn that potassium citrate may be a contributor to irritative voiding symptoms. A causative relation between diet and disease is recognized for a number of food substances and body organs. Participants completed a Block’s FFQ, the American Urological Association (AUA) Symptoms score sheet, 3-day voiding diary and 3-day food record. Eleven participants completed the 12-day diet study. Study utilized randomized crossover and participants were divided into two groups. For the first 6 days one group was given a placebo and the other potassium citrate, then for the final 6 days the administering was switched. Potassium citrate and placebo were taken during morning and evening meals. A total of 40 mEq of potassium was consumed per day for six days. On days 1, 3, 6, 9, and 12 participants completed AUA Symptoms score sheet, voiding diary and 24 hour urine samples. Comparisons between and within groups were made by repeated-measures analysis of variance. Change regarding urgency between groups from baseline to Day 12 was significant (P ⬍ .05). Two-way repeated measures suggest that urgency symptom changed over time during the six days when 40 mEq potassium citrate was consumed. The AUA Symptoms score sheet was used to report participants irritative voiding symptoms every three days of the 12-day study. Statistical significance was noted in quality of life scores between baseline and Day 6 and between baseline and Day 12 (P ⬍ .05). Results suggest that quality of life scores for both groups were the same at baseline but changed over time. Results suggest that potassium citrate (40 mEq) contributed to reported symptom variations. Funding Disclosure: WSU Seed Grant
Journal of the AMERICAN DIETETIC ASSOCIATION / A-41